MHM. Maruf Hasan

M. Maruf Hasan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


M. Maruf Hasan has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Thermophysical and Spectroscopic Investigation of Binary Mixtures of Cumene with Pentan-1-ol and Hexan-1-ol at Temperatures from 298.15 to 323.15 K

    by M. Ashraf Uddin, M. Maruf Hasan, M. Mehedi Hasan Rocky, Abul Fazal M. Sanaullah, Ismail Rahman

    Densities (ρ) and viscosities (η) of binary mixtures of cumene with pentan-1-ol and hexan-1-ol were measured over the full composition range at (298.15–323.15) K and 0.10 MPa. From these experimental data, excess molar volumes (VmE), partial molar volumes (V̅i), viscosity deviations (Δη), isobaric thermal expansivities (α) and their excess values (αE), and excess Gibbs free energies of activation for viscous flow (ΔG≠E) were calculated to elucidate the nature of intermolecular interactions. For both systems, VmE values were mostly positive, whereas Δη and ΔG≠E were negative, indicating disruption of alcohol self-association, volume expansion upon mixing, and reduced resistance to viscous flow. The magnitude of VmE increased with temperature but decreased with alcohol chain length, reflecting stronger dispersive contributions in the hexan-1-ol system. FT-IR spectra of equal-volume mixtures showed blue shifts (∼25–26 cm–1) in the O–H stretching band, confirming hydrogen-bond weakening and possible weak O–H···π interactions. Excess properties were well correlated by the Redlich–Kister equation, while the Jouyban–Acree model accurately represented ρ and η. Among the viscosity models examined, the Ausländer and McAllister four-body models provided the best performance.

  • Open Access

    In-silico approach to designing effective antiviral drugs against SARS-CoV-2 and SARS-CoV-1 from reported phytochemicals: a quality improvement study

    by Fatema- Bsc Tuz-Zohura, Abu R.Md. Bsc Shawon, Md. Maruf Bsc Hasan, Abdullah Bsc Aeyas, Faisal I. Chowdhury, Mayeen U. Khandaker

    Computer-aided drug design by molecular docking, statistical analysis like multiple linear regression (MLR), principal component analysis (PCA), and molecular dynamics studies can emerge as an efficient approach to designing promising core scaffolds for coronavirus medication. The main protease [3-chymotrypsin-like protease (3CLpro)] of severe acute respiratory syndrome coronavirus (SARS-CoV)-1 and SARS-CoV-2 is one of the critical targets for designing and developing broad-spectrum antiviral therapeutic drugs. The main objective of this study was to investigate potential phytochemicals against SARS-CoV-1 and SARS-CoV-2 to ensure effective natural product-induced therapy. In this evaluation, we have selected 40 reported phytochemicals to design efficient core scaffolds that can act as potent inhibitors against the main proteases of SARS-CoV-2 and SARS-CoV-1. We categorized the selected phytochemicals into a more bioavailable and less bioavailable set, considering phytochemical drug likeliness properties. All the selected phytochemicals vigorously interacted with the catalytic dyads His41 and Cys145. Statistical analysis by MLR confirmed their contribution to structural features on binding affinities and PCA analysis for structural activity relationships for their structural pattern recognition to determine the core scaffold inhibitors. We confirmed that 4′-Hydroxyisolonchocarpin and BrussochalconeA were safe and exhibited excellent pharmacological properties. Because 4′-Hydroxyisolonchocarpin and BrussochalconeA are flavonoid derivatives, they exhibit the chalcone’s ring. The presence of the reactive α,β-unsaturated system in the chalcone’s rings showed different potential pharmacokinetics with an insignificant toxicological profile. Our comprehensive computational and statistical analysis reveals that these selected phytochemicals (4′-Hydroxyisolonchocarpin, BrussochalconeA) can be used to design potential broad antiviral inhibitors against SARS-CoV-2 and SARS-CoV-1.


  • Open Access

    In-silico approach to design effective antiviral drugs against SARS- CoV-2 and SARS-CoV-1 from reported phytochemicals

    by Fatema-Tuz-Zohura Fatema-Tuz-Zohura, Abu Rashed Md. Sh, Maruf Hasan, Abdullah Aeyas, Faisal I. Chowdhury

    Computer-aided drug design by molecular docking, statistical analysis like multiple linear regression (MLR), principal component analysis (PCA), and molecular dynamics studies can emerge as an efficient approach to design promising core scaffolds for coronavirus medication. The main protease (3CLpro) of SARS-CoV-2 and SARS-CoV-1 is one of the critical targets for designing and developing broad-antiviral therapeutic drugs. In this evaluation, we have selected 40 reported phytochemicals to design the efficient core scaffolds, which can act as a potent inhibitor against the main protease of SARS-CoV-2 and SARS-CoV-1. We categorized the selected phytochemicals into a more bioavailable and less bioavailable set considering phytochemical drug likeliness properties. All the selected phytochemicals vigorously interact with the catalytic dyad His41 and Cys145. Statistical analysis MLR has confirmed their contribution to structural features on binding affinities and PCA analysis for structural activity relationship (SAR) for their structural pattern recognition to determine the core scaffolds inhibitors. We have confirmed that 4'-Hydroxyisolonchocarpin, and BrussochalconeA, are safe and exhibit good pharmacological properties. Our comprehensive computational and statistical analysis reveals that these selected phytochemicals (4'-Hydroxyisolonchocarpin, BrussochalconeA) can be used to design potential broad-antiviral inhibitors against the SARS-CoV-2 and SARS-CoV-1.